Navigation Links
American Pacific Reports Fiscal 2011 Results
Date:12/14/2011

60; The purchase of this facility was accounted for as a capital expenditure.

Financing Cash Flows  Cash used for financing activities in Fiscal 2011 relates primarily to costs associated with establishing our asset based lending facility in January 2011.  Cash used for financing activities in Fiscal 2010 relates to our repurchase and cancellation of $5.0 million in principal amount of our senior notes.OUTLOOKFor Fiscal 2012, we expect consolidated revenues of at least $220.0 million, reflecting the following:

  • Fine Chemicals segment revenues are anticipated to increase by at least 15% in Fiscal 2012.  The anticipated increase is supported by expected growth in revenues from our most significant anti-viral product as we enter into the first full year of production for this product under the renewed three-year supply agreement.
  • Specialty Chemicals segment revenues are expected to decline by up to 10% in Fiscal 2012, which we believe is within the expected stable range for this non-growth segment. 
  • Aerospace Equipment segment revenues are anticipated to grow modestly in Fiscal 2012. Fiscal 2011 was a year of substantial revenue growth for this segment.  The average growth rate of Fiscal 2011 and Fiscal 2012 combined should result in a normalized expectation for this segment.
  • Our guidance for Fiscal 2012 Adjusted EBITDA is at least $35.0 million.  The increase reflects:

  • Fine Chemicals segment profitability is anticipated to improve substantially in Fiscal 2012. To achieve these improvements, we are targeting process improvements which enhance manufacturing throughput and product yields.  We do not anticipate reaching these targets until late in Fiscal 2012.
  • Profit contribution from our Specialty Chemicals segment is expected to decline in Fiscal 2012.  This is consistent with the anticipated reduction in revenues and the transition bac
    '/>"/>

  • SOURCE American Pacific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
    4. Aspirin Named 8th World Wonder by Majority of Americans
    5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
    6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
    7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
    8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
    9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
    10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
    11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/15/2014)... and BRUSSELS , Sept. ... ) and UCB (Euronext Brussels:UCB) today announced results from ... romosozumab in postmenopausal women with low bone mineral density ... designed to work by inhibiting the protein sclerostin, thereby ... were presented at the American Society for Bone and ...
    (Date:9/15/2014)... -- myMatrixx has extended its contract with its Medical ... role that includes direct involvement in the myMatrixx clinical ... physiatrist and pain management specialist, published author, and frequent ... is Board Certified in physical medicine and rehabilitation and ... and subspecialty boarded by the American Board of Anesthesia. ...
    (Date:9/15/2014)... The Society of Corporate Compliance and ... than 4,500 compliance and ethics professionals from across ... corporate fines and settlements.  The SCALENDAR is designed ... ready reference to demonstrate to employees the consequences ... to help compliance and ethics officers looking for ...
    Breaking Medicine Technology:New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 2New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 3New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 5New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 6New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 7New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 8New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 10New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 11New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 12New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 13New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 14New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 15myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2
    ... Aug. 29, 2011 Elekta announced it has ... treatment control system in the European Union. Integrity ... variable dose rate (CVDR) and interdigitation capabilities for ... complete range of delivery techniques -- such as ...
    ... Cardium Therapeutics (NYSE Amex: CXM ) ... designed to reestablish compliance with its exchange listing requirements ... of a revenue-generating nutraceutical business designed to expand the ... Company announced the incorporation of MedPodium Health Sciences, Inc., ...
    Cached Medicine Technology:New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 2New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 3Cardium Provides Update on Exchange Listing and Related Business Matters 2Cardium Provides Update on Exchange Listing and Related Business Matters 3Cardium Provides Update on Exchange Listing and Related Business Matters 4Cardium Provides Update on Exchange Listing and Related Business Matters 5
    (Date:9/15/2014)... Transvaginal mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) ... in the federal multidistrict litigation now underway in U.S. ... LLP reports. According to documents filed in the proceeding, ... that provides for the severance of several actions in ... affected plaintiffs has objected to severance of the cases. ...
    (Date:9/15/2014)... to recent studies, approximately one out of every 40 individuals ... responsible for spinal muscular atrophy (SMA), a neurodegenerative disease that ... University of Missouri have made a recent breakthrough with the ... in animal models of the disease. In April, a patent ... "The strategy our lab is using to fight SMA is ...
    (Date:9/15/2014)... Alto, CA (PRWEB) September 15, 2014 ... anniversary since its founding in 2007. To mark the ... local community for supporting the village and helping it ... provides a safe, secure and fun community for seniors. ... to the community and live in their own homes. ...
    (Date:9/15/2014)... (HealthDay News) -- Births of multiple babies cost more ... singleton births, researchers report. The researchers suggest that ... (IVF) could ease some of that burden. Over ... tandem with births to older mothers and use of ... of New South Wales, Australia. Their study, published ...
    (Date:9/15/2014)... (PRWEB) September 15, 2014 Providing ... Cherry Bekaert LLP (“the Firm”) is ... as a Director with the Firm’s Litigation ... 25 years of experience, Wolf will assist clients ... advisory and transactional advisory matters. He will also ...
    Breaking Medicine News(10 mins):Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 3
    ... deadly, say authors of a new survey , , TUESDAY, May ... level of driving experience, putting them at risk for accidents ... many teens recognize that drinking and driving don,t mix, many ... having friends in the car. , "We listened to teenagers ...
    ... Provided for Successfully Tackling This Valuable ... Part of Her ... on their,plates -- from carpool queen to coach, counselor to chef. It,s ... childhood,obesity and inadequate nutrition, many moms have taken on yet another,important role ...
    ... announced financial,and operating results for its first quarter ended March 31, ... percent to $7.127 billion. -- Net income totaled $170 million, ... year,s first quarter. -- Adjusted EBITDA totaled $1.180 billion, compared ... of 2007. -- Provision for doubtful accounts increased to $888 ...
    ... 6 , - International Reach of ,Young ... For the first time, a researcher from ... (APA) prestigious "Young Minds in,Psychiatry" awards, which were ... Washington, DC. The awards, supported by an educational ...
    ... Hope, fundraising efforts honor Marcus,s dog Tasha and her ... life-threatening blood disorder, DENVER, May 6 Racing driver ... 2008 season race proceeds from their new,BMW Z4 M Coupe ... (MAF). All donations to Meisha,s Hope are used to fund ...
    ... Market Research Reveals, CHICAGO, May 6 ... in the new three-dimensional research study --,Understanding Gluten ... international findings deliver an innovative 360 degree view,of ... qualitative,insights from customers living with food allergies, celiac ...
    Cached Medicine News:Health News:Many Teen Drivers Don't Think They're Inexperienced 2Health News:Many Teen Drivers Don't Think They're Inexperienced 3Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 2Health News:Got Milk? Campaign Will Recognize and Reward Moms for Their Role as the Family's Chief Health Officer 3Health News:HCA Reports First Quarter 2008 Results 2Health News:HCA Reports First Quarter 2008 Results 3Health News:HCA Reports First Quarter 2008 Results 4Health News:HCA Reports First Quarter 2008 Results 5Health News:HCA Reports First Quarter 2008 Results 6Health News:HCA Reports First Quarter 2008 Results 7Health News:HCA Reports First Quarter 2008 Results 8Health News:HCA Reports First Quarter 2008 Results 9Health News:HCA Reports First Quarter 2008 Results 10Health News:HCA Reports First Quarter 2008 Results 11Health News:HCA Reports First Quarter 2008 Results 12Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 2Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 3Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 4Health News:The American Psychiatric Association's Awards for Young Scientists Encourage Research Expertise in China 5Health News:Racing Professional Steve Marcus Pledges Season BMW Proceeds to Morris Animal Foundation's Meisha's Hope Fund 2Health News:80% of Customers Eat Out Less Due to Food Allergies and Celiac / Coeliac Disease Impacting Quality of Life 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: